{
    "report_title": "Cryogenic Biobanking Services Industry Report",
    "report_date": "2023",
    "key_statistics": {
        "revenue": {
            "revenue_dollars": 5811000000,
            "revenue_cagr_historical": {
                "begin_year": 2003,
                "end_year": 2023,
                "revenue_cagr_value": 5.44
            },
            "revenue_cagr_projected": {
                "begin_year": 2023,
                "end_year": 2029,
                "revenue_cagr_value": 2.0
            }
        },
        "profit": {
            "profit_dollars": 209000000,
            "profit_cagr_historical": {
                "begin_year": 2005,
                "end_year": 2023,
                "profit_cagr_value": 1.63
            },
            "profit_cagr_projected": {
                "begin_year": 2023,
                "end_year": 2029,
                "profit_cagr_value": null
            }
        },
        "profit_margins": {
            "profit_margins_percentage": 3.6,
            "profit_margins_cagr_historical": {
                "begin_year": 2005,
                "end_year": 2023,
                "profit_margins_cagr_value": -4.07
            },
            "profit_margins_cagr_projected": {
                "begin_year": 2023,
                "end_year": 2029,
                "profit_margins_cagr_value": null
            }
        },
        "industry_value_added": {
            "industry_value_added_dollars": 2109000000,
            "industry_value_added_cagr_historical": {
                "begin_year": 2003,
                "end_year": 2023,
                "industry_value_added_cagr_value": 5.56
            },
            "industry_value_added_cagr_projected": {
                "begin_year": 2023,
                "end_year": 2029,
                "industry_value_added_cagr_value": 2.65
            }
        },
        "employees": {
            "employees_count": 31121,
            "employees_cagr_historical": {
                "begin_year": 2003,
                "end_year": 2023,
                "employees_cagr_value": 6.4
            },
            "employees_cagr_projected": {
                "begin_year": 2023,
                "end_year": 2029,
                "employees_cagr_value": 3.09
            }
        },
        "wages": {
            "wages_dollars": 1715000000,
            "wages_cagr_historical": {
                "begin_year": 2003,
                "end_year": 2023,
                "wages_cagr_value": 5.9
            },
            "wages_cagr_projected": {
                "begin_year": 2023,
                "end_year": 2029,
                "wages_cagr_value": 2.88
            }
        },
        "imports": {
            "imports_dollars": null,
            "imports_cagr_historical": {
                "begin_year": null,
                "end_year": null,
                "imports_cagr_value": null
            },
            "imports_cagr_projected": {
                "begin_year": null,
                "end_year": null,
                "imports_cagr_value": null
            }
        },
        "exports": {
            "exports_dollars": null,
            "exports_cagr_historical": {
                "begin_year": null,
                "end_year": null,
                "exports_cagr_value": null
            },
            "exports_cagr_projected": {
                "begin_year": null,
                "end_year": null,
                "exports_cagr_value": null
            }
        }
    },
    "executive_summary": "The Cryogenic Biobanking Services industry is a critical resource for modern scientific research, particularly with respect to disease researchers, pharmaceutical companies and biotechnology researchers. Using cryogenic storage facilities to house samples, companies in this industry catalog biospecimens by genetic or environmental characteristics for use by researchers who require specimens with these traits. Biobanks have become an increasingly vital tool in medical research by producing studies and innovations that have improved public health outcomes. As a result, funding allocated toward biobanks has accelerated.",
    "current_performance": [
        {
            "current_performance_point_title": "A Collaborative Effort: Affiliations in the Biobanking Industry",
            "current_performance_point_description": "- Majority of biobanks reported being affiliated with larger organizations such as academic institutions, hospitals and research institutions. - A small number operate as for-profit organizations, indicating a broader focus on reinvesting into biorepositories and resource improvement. - Affiliations are vital in creating a collaborative biomedical research environment that can advance disease research and drug development."
        },
        {
            "current_performance_point_title": "Compliance Costs and Technology Investments Impact Profit",
            "current_performance_point_description": "The role of biobanks in critical medical research has expanded extensively. Concurrently, questions regarding the industry's legal, societal, environmental and ethical implications have been raised. For instance, while electronic health records (EHRs) have become widely adopted across the broader healthcare sector to improve patient privacy, collecting, storing and sharing human samples at industry facilities poses several challenges that could risk crucial funding. In addition, data insecurity and privacy concerns can result in underutilization or withdrawals at facilities. Thus, compliance costs and investment into new tech advancements have limited growth in the profit margin despite significant revenue growth during the same period. Industry profit, measured as earnings before interest and taxes, is anticipated to stay at 3.6% in 2023."
        },
        {
            "current_performance_point_title": "Revenue Growth Over Five Years to 2023",
            "current_performance_point_description": "Over the five years to 2023, industry revenue is expected to increase at an annualized rate of 6.0% to $5.8 billion, including a 9.1% jump in 2023."
        }
    ],
    "future_outlook": [
        {
            "future_outlook_point_title": "The Cryogenic Biobanking Services Industry's Expanding Role",
            "future_outlook_point_description": "The Cryogenic Biobanking Services industry will play a more significant role in essential infrastructure development. As research derived from biobanks becomes more vital in disease prevention and drug development, federal funding for businesses will expand as these scientific advancements can pose essential implications for the future of public health and overall economic well-being. Overall, industry revenue is forecast to grow at an annualized rate of 2.1% to $6.5 billion over the five years to 2028."
        },
        {
            "future_outlook_point_title": "The Impact of COVID-19 on Biobanking",
            "future_outlook_point_description": "The COVID-19 pandemic has increased demand for biobanking services, spurring growth in the industry. - Biobanks have played an essential role in studying the virus by offering resources for comparing cases worldwide. - This increased demand and involvement point to the crucial role of biobanks in a society grappling with a pandemic. - Pandemic also introduced new challenges related to specimen storage and transplant screening procedures to ensure safety."
        },
        {
            "future_outlook_point_title": "Ongoing Challenges: Funding and Specialization Conundrums",
            "future_outlook_point_description": "- Funding represents a significant challenge for biobanks, with federal government grants being the most critical funding source. - Starting a biobank requires a significant investment and it often takes years for revenue to reach a sustainable level. - Many biobanks analyze and preserve specimens targeted toward specific diseases, making them crucial players in precision medicine. - Despite the challenges, expectations are optimistic about the future expansion of companies, driven by growing research activities and health expenditure."
        },
        {
            "future_outlook_point_title": "Biobanking Cooperation Essential for Growth",
            "future_outlook_point_description": "- Biobanks will increasingly cooperate to share data and develop adequate clinical trials, providing larger biospecimen sample sizes. The collaborative approach allows biobanks to benefit from shared resources and expertise within their organizations, aiding in improving and expanding services."
        }
    ],
    "industry_definition": "This industry operates cryogenic storage facilities used to archive biological samples used for research. Biobanks, or repositories that store these.",
    "industry_impact": {
        "positive_impact_factors": [
            "Capital Intensity Level low",
            "Industry Assistance Level high - increasing",
            "Concentration Level low",
            "Globalization Level low - increasing",
            "Competition Level low - increasing"
        ],
        "negative_impact_factors": [
            "Technology Change Level high"
        ],
        "mixed_impact_factors": []
    },
    "swot_analysis": {
        "strengths": [
            "High & Increasing Level of Assistance",
            "Low Competition",
            "Growth Life Cycle Stage",
            "Low Imports",
            "Low Customer Class Concentration",
            "Low Product/Service Concentration",
            "Low Capital Requirements"
        ],
        "weaknesses": [
            "Low Profit vs. Sector Average"
        ],
        "opportunities": [
            "High Revenue Growth (2005-2023)",
            "High Revenue Growth (2018-2023)",
            "High Revenue Growth (2023-2028)",
            "High Performance Drivers",
            "Government funding for universities"
        ],
        "threats": [
            "Low Outlier Growth",
            "OD - Regulation"
        ]
    },
    "key_trends": [
        "Biobanks play an essential role in biomedical research. They have proven particularly critical during the COVID-19 pandemic, providing resources for widespread case comparison and facilitating studies on the virus.",
        "Biobanks need cooperation for growth. This involves data-sharing, transparency, adequate clinical trials and fostering partnerships, with a particular focus on DNA sequencing and ethical regulations.",
        "The FDA sets safety standards for organ and tissue operations. They oversee every stage, from collection to transportation, to ensure the safety of both donors and recipients.",
        "Federal and state governments are critical funders of cryogenic biobanking services. They provide financial assistance, guidance and support for the industry's operations, research and ethical considerations.",
        "Biobanks aid in medical research by providing diverse biological specimens for studying diseases and understanding genetic traits.",
        "Federal funding is crucial for biobanking services as it significantly aids in their expansion and promotes inter-institutional research collaborations.",
        "The Southeast provides an ideal climate for biobanking as the region's mild weather eases maintaining the required ultra-low temperatures for sample preservation, attracting Cryogenic Biobanking facilities infrastructure.",
        "The Southwest's medical and biotech sectors fuel biobanking demand as the region's biotech growth and medical tourism increase the need for long-term sample storage through Cryogenic Biobanking Services.",
        "Biobanks compete on quality factors such as quality of specimens, user-friendly databases and secure, efficient systems, underlining the importance of experts and advanced technologies.",
        "National biobanks pose a challenge to independent ones as the growth and establishment of national biobanks, like caHUB, could threaten smaller biobanks due to their ability to offer standardized, high-quality specimens and evaluate vast patient data.",
        "Despite a competitive market, no clear industry leader has emerged in the US Cryogenic Biobanking Services due to a diverse landscape of specialized providers catering to different research niches, preventing a single company from dominating the entire sector.",
        "High compliance costs and technology investments impact Biobanks' profit as the need for better data collection, storage and privacy issues results in considerable expenditure, affecting their overall profitability."
    ],
    "market_segmentation": [
        {
            "segment": "Federal government",
            "segment_description": "In the Cryogenic Biobanking Services industry, the Federal government is the principal funding source, playing a significant role in its expansion. Standardizing donor consent forms, data collection and sharing systems can boost the industry, promoting inter-institutional collaborations for researching human diseases.",
            "segment_percentage": 41.9
        },
        {
            "segment": "Parent organization",
            "segment_description": "Parent organizations, like academic institutions, pharmaceutical companies, biotechnology businesses and hospitals, often incorporate biobanks as essential divisions. While examining potential cost leakages, these organizations rely heavily on biobanks for their operations, notably pharmaceutical companies that require biological samples to ascertain drug efficacy.",
            "segment_percentage": 24.0
        },
        {
            "segment": "Other",
            "segment_description": "Other miscellaneous sources also lend to the industry's total revenue.",
            "segment_percentage": 15.1
        },
        {
            "segment": "Fee-for-service",
            "segment_description": "Fee-for-service in biobanking involves charging clients for the storage of biospecimens. This revenue stream has remained stagnant as the value proposition of such services has been challenging to communicate to potential clients. Strong federal funding has mitigated its importance for biobanks' survival till now.",
            "segment_percentage": 9.7
        },
        {
            "segment": "Donations",
            "segment_description": "Contributions from individuals or foundations make up a vital source of income for biobanks. Health-oriented foundations expressly set aside some of their resources for biobanks, aiding significant disease and disorder research.",
            "segment_percentage": 8.6
        }
    ],
    "products_and_services": [
        {
            "product_or_service": "Whole Blood and Peripheral Blood Cells",
            "product_description": "Blood and blood cells are the most prevalent specimens in biobanks, offering a valuable resource for a wide range of studies. These samples, which include whole blood, blood plasma and peripheral blood cells, allow for the extraction and analysis of deoxyribonucleic acid (DNA) data.",
            "product_percentage": 48.9
        },
        {
            "product_or_service": "Serum or Plasma",
            "product_description": "Serum and plasma storage in biobanks are significant due to their role in identifying a patient's risk for serious health issues such as bone marrow disorders, HIV, inflammatory bowel diseases, kidney disease, leukemia, liver disease and other diseases.",
            "product_percentage": 21.8
        },
        {
            "product_or_service": "Urine and Stool",
            "product_description": "Urine, stool and other pathological bodily fluids are key in researching diseases and understanding genetic traits. Biobanks are crucial for these samples, with mouth cells and saliva beneficial for yielding DNA samples. High-quality DNA samples can be derived from saliva, providing an effective alternative to blood DNA samples. Fecal transplants, a procedure leveraging stool samples, show promising potential in treating complex conditions like ulcerative colitis, signaling a future rise in demand for such samples.",
            "product_percentage": 10.5
        },
        {
            "product_or_service": "Cell Lines",
            "product_description": "Cell lines are biological models that enable researchers to study genetic diseases. Through cryogenic preservation, human biospecimens can be stored and examined for understanding disease mechanisms and disorders. Cell lines can be requested explicitly from companies for biomedical research. The use of cell lines is projected to contribute to industry revenue in the future significantly.",
            "product_percentage": 10.2
        },
        {
            "product_or_service": "Cerebral Spinal Fluid",
            "product_description": "Cerebral spinal fluid is a valuable resource in studying neurological diseases. Its importance in research propels it as a substantial contributor to the biomedical industry revenue.",
            "product_percentage": 5.4
        },
        {
            "product_or_service": "Other",
            "product_description": "Besides commonly collected samples like blood and tissue, biobanks also provide a wide range of other biological specimens, including hair, toenails, corneas, etc. These unconventional samples are significant resources for researchers, allowing them to explore new aspects of diseases and their treatments. Other biological specimens are defined as non-blood and non-tissue samples, offering an alternative or additional source of information to enrich.",
            "product_percentage": 2.7
        }
    ],
    "supply_chain": {
        "tier_1_suppliers": [
            "Data Processing & Hosting Services in the US",
            "Medical Device Manufacturing in the US"
        ],
        "tier_2_suppliers": [
            "Heating & Air Conditioning Equipment Manufacturing in the US",
            "Organic Chemical Manufacturing in the US",
            "Medical Instrument & Supply Manufacturing in the US"
        ],
        "tier_1_buyers": [
            "Scientific Research & Development in the US",
            "Hospitals in the US"
        ],
        "tier_2_buyers": [
            "Scientific Research & Development in the US",
            "Diagnostic & Medical Laboratories in the US",
            "Hospitals in the US",
            "Colleges & Universities in the US",
            "Biotechnology in the US"
        ]
    },
    "demand_determinants": [
        {
            "determinant_title": "Research and Development Expenditure",
            "determinant_description": "Downstream researchers are gradually realizing the importance of industry samples for research and development (R&D). There has also been a historic shortage of viable clinical models the industry offers. Consequently, an increase in expenditure on R&D tends to boost demand for biospecimens provided by companies. R&D expenditure is expected to increase in 2023, representing a potential opportunity to the industry."
        },
        {
            "determinant_title": "Government Consumption and Investment",
            "determinant_description": "Government investment supporting cryogenic banking providers funds research opportunities and workforce development. Developing a workforce and new tech advances are critical to the industry's long-term growth. Government investment is anticipated to expand in 2023."
        }
    ],
    "international_trade": {
        "import_level": "Low",
        "import_trend": "Steady",
        "export_level": "Low",
        "export_trend": "Steady",
        "international_trade_points": []
    },
    "business_locations": [
        {
            "location": "Northeast",
            "location_description": "The Northeast region has the highest concentration with 26 business locations.",
            "percentage_establishments": 26.0,
            "percentage_population": 101.0
        },
        {
            "location": "West",
            "location_description": "The West region has 24 business locations.",
            "percentage_establishments": 24.0,
            "percentage_population": 19.6
        },
        {
            "location": "Southeast",
            "location_description": "The Southeast region has 8 business locations. The Southeast is packed with renowned research universities, medical institutions, and biotech companies, fueling demand for Cryogenic Biobanking Services. Due to the varied demographics, the healthcare landscape in the Southeast presents a wide range of health conditions demanding extensive biobanking for studies. The region's milder weather simplifies maintaining the ultra-low temperatures required for sample preservation, making it an appealing location for Cryogenic Biobanking facilities.",
            "percentage_establishments": 8.0,
            "percentage_population": 21.7
        },
        {
            "location": "Southwest",
            "location_description": "The Southwest region has 6 business locations. The rapid growth of biotech startups and research centers has resulted in robust demand for Cryogenic Biobanking Services in the Southwest region. Known for world-class healthcare facilities and pioneering treatments, the Southwest region draws medical tourism; Cryogenic Biobanking Services thus cater to international patients seeking long-term sample storage. Favourable policies and lower operational costs lure biotech businesses and startups, boosting the need for reliable Cryogenic Biobanking for storing biological samples critical for research, development, and clinical trials.",
            "percentage_establishments": 6.0,
            "percentage_population": 11.5
        },
        {
            "location": "Mid-Atlantic",
            "location_description": "The Mid-Atlantic region has 6 business locations.",
            "percentage_establishments": 6.0,
            "percentage_population": 13.4
        },
        {
            "location": "Plains",
            "location_description": "The Plains region has 4 business locations.",
            "percentage_establishments": 4.0,
            "percentage_population": 6.8
        },
        {
            "location": "Great Lakes",
            "location_description": "The Great Lakes region has 1 business location. Top-tier research universities and medical centers in the Great Lakes region generate strong demand for Cryogenic Biobanking Services. The significant presence of biotech and pharmaceutical companies creates a constant need for long-term sample storage, contributing to the Cryogenic Biobanking demand.",
            "percentage_establishments": 1.0,
            "percentage_population": 15.1
        },
        {
            "location": "Rocky Mountains",
            "location_description": "The Rocky Mountains region has 1 business location.",
            "percentage_establishments": 1.0,
            "percentage_population": 7.4
        }
    ],
    "regulations_and_policies": {
        "regulations_level": "Moderate",
        "regulations_points": [
            {
                "regulation_title": "The Food and Drug Administration",
                "regulation_description": "The FDA oversees collecting, testing, processing, storing, and transporting blood, tissue, and organs. It sets standards and conducts inspections."
            },
            {
                "regulation_title": "The National Organ Transplant Act",
                "regulation_description": "The NOTA of 1984 prohibits the sale of human organs in the US. It established networks to facilitate organ matching and transplantation."
            },
            {
                "regulation_title": "The National Organ Procurement and Transplantation Network",
                "regulation_description": "The NOPTN tracks donated organs and issued COVID-19 guidelines for organ banking to ensure safety of transportation and transplantation."
            },
            {
                "regulation_title": "The World Medical Association",
                "regulation_description": "The WMA's Declaration of Helsinki provides guidelines emphasizing informed consent for using human tissues and organs to safeguard research participants' rights."
            }
        ],
        "regulations_trend": "Increasing"
    },
    "barriers_to_entry": {
        "barriers_level": "Moderate",
        "barriers_trend": "Increasing",
        "barriers_points": [
            {
                "barrier_title": "Requirement for highly skilled professionals",
                "barrier_description": "The requirement for highly skilled professionals in Cryogenic Biobanking, who are proficient in collecting, preserving, and managing samples, acts as a deterrent for newcomers in the field. Recruiting and retaining such specialized talent is a significant challenge."
            }
        ],
        "factors_increased_barrier": [
            "Technology Change Level: high"
        ],
        "factors_decreased_barrier": [
            "Capital Intensity Level: low",
            "Industry Assistance Level: high - increasing",
            "Concentration Level: low",
            "Globalization Level: low - increasing",
            "Competition Level: low - increasing"
        ]
    },
    "basis_of_competition": {
        "basis_level": "Low",
        "basis_trend": "Increasing",
        "basis_points": [
            {
                "basis_title": "Quality factors",
                "basis_description": "Biobanks compete on quality factors. Quality of specimens, user-friendly databases and secure, efficient systems are key competitive factors for biobanks, underlining the importance of experts and advanced technologies."
            },
            {
                "basis_title": "Competition from national biobanks",
                "basis_description": "National biobanks pose a challenge to independent ones. The growth and establishment of national biobanks, like caHUB, could threaten smaller biobanks due to their ability to offer standardized, high-quality specimens and evaluate vast patient data."
            }
        ]
    },
    "market_share_concentration": {
        "concentration_level": "Low",
        "concentration_trend": "Steady",
        "concentration_points": [
            {
                "concentration_title": "Industry fragmentation",
                "concentration_description": "The Cryogenic Biobanking Services industry is populated mainly by small operating companies. These small companies often specialize in regional services or specific diseases."
            },
            {
                "concentration_title": "Decentralized research system",
                "concentration_description": "The decentralized and fragmented research system in the US does not provide biobanks with adequate tools to propel growth. The persistently low concentration level in the industry can be attributed to this factor."
            }
        ],
        "top_companies": []
    },
    "cost_structure_breakdown": [
        {
            "cost_type": "Profit",
            "cost_type_percentage": 101
        },
        {
            "cost_type": "Wages",
            "cost_type_percentage": 29.5
        },
        {
            "cost_type": "Purchases",
            "cost_type_percentage": 12.9
        },
        {
            "cost_type": "Depreciation",
            "cost_type_percentage": 101
        },
        {
            "cost_type": "Marketing",
            "cost_type_percentage": 101
        },
        {
            "cost_type": "Rent",
            "cost_type_percentage": 101
        },
        {
            "cost_type": "Utilities",
            "cost_type_percentage": 101
        },
        {
            "cost_type": "Other",
            "cost_type_percentage": 101
        }
    ],
    "cost_factors": [
        {
            "cost_factor_title": "High Operational Costs and Revenue Factors",
            "cost_factor_description": "Purchases are expected to account for 12.9% of industry revenue in 2023. Case collection, tissue and biospecimen acquisition, is one of the significant cost burdens. Processing costs also form a substantial part of the expense. Storage management and distribution operations account for a significant proportion of revenue."
        },
        {
            "cost_factor_title": "Capital-Intensive but Labor-Dependent Industry",
            "cost_factor_description": "In 2023, wages are expected to account for 29.5% of total revenue. Despite capital investment, labor is integral for storage management, auditing, certification, inventory control, entry management, order verification, shipping and working with biospecimens. Skilled laborers receive relatively high wages."
        }
    ],
    "capital_intensity": {
        "capital_intensity_level": "Low",
        "capital_intensity_points": [
            {
                "capital_intensity_title": "Low capital intensity",
                "capital_intensity_description": "The industry is experiencing a low level of both the rate of new patents and the concentration of patents in the industry."
            }
        ],
        "capital_intensity_trend": "Steady"
    },
    "revenue_volatility": {
        "volatility_level": "Moderate",
        "volatility_points": [
            {
                "volatility_title": "Driving Forces Behind the Demand for Cryogenic Biobanking Services",
                "volatility_description": "The industry encounters consistent demand due to biobank storage needs by research entities, healthcare facilities and biotech companies. Demand can escalate during global health emergencies."
            },
            {
                "volatility_title": "Funding Uncertainty Undermining Growth of Cryogenic Biobanking Services",
                "volatility_description": "Revenue demonstrated moderate volatility due to dependencies on federal government funding. Fluctuations in this funding can substantially affect industry revenue despite rising biospecimen demand."
            }
        ],
        "volatility_trend": "Steady"
    },
    "technological_change": {
        "technological_change_level": "High",
        "technological_change_points": [
            {
                "technological_change_title": "Vital Role of Blood and Blood Cells in Biobank Research",
                "technological_change_description": "Blood and blood cells are the most prevalent biobank specimens, offering a valuable resource for genetic trait studies. Categorized by donor characteristics, they allow DNA extraction and analysis."
            },
            {
                "technological_change_title": "Unlocking the Power of Serum or Plasma in Health Industry",
                "technological_change_description": "Serum and plasma storage identify patient risk for serious health issues like bone marrow disorders. Demand for blood samples is projected to increase, reinforcing their importance."
            },
            {
                "technological_change_title": "Discovering the Potentials of Cell Lines in Disease Research and Drug Therapy",
                "technological_change_description": "Cell lines enable studying genetic diseases through cryogenic preservation. Their use in biomedical research is projected to contribute significantly to industry revenue."
            },
            {
                "technological_change_title": "Decoding Health Mysteries Through Urine, Stool and Other Pathological Bodily Fluids",
                "technological_change_description": "Urine, stool and other bodily fluids are key in disease and genetic research. Mouth cells and saliva yield valuable DNA samples as blood alternatives."
            },
            {
                "technological_change_title": "CEREBRAL SPINAL FLUID: AN INCREASINGLY SIGNIFICANT DRIVER IN BIOMEDICAL INDUSTRY REVENUE",
                "technological_change_description": "Cerebral spinal fluid is valuable for studying neurological diseases, propelling it as a substantial contributor to biomedical industry revenue with rising collaborative research efforts."
            },
            {
                "technological_change_title": "FERTILITY SPECIMENS: A NICHE MARKET TRENDING UPWARDS",
                "technological_change_description": "Fertility specimens like stored sperm and eggs are becoming popular, catering to those planning parenthood around careers, though still a minor industry proportion."
            },
            {
                "technological_change_title": "UNEARTHING THE POTENTIAL OF OTHER BIOLOGICAL SPECIMENS IN BIOBANKS",
                "technological_change_description": "Besides common samples, biobanks provide unconventional specimens like hair, toenails, corneas, allowing exploration of new disease aspects and treatments."
            }
        ],
        "technological_change_trend": "Increasing"
    },
    "FAQs": [
        {
            "question": "How can your company or organization partner with schools, universities, hospitals and other entities to encourage use of cryogenic banking services?",
            "answer": "Universities and medical research departments nationwide maintain biobanks on their campuses. These institutions often utilize government research grants to establish and run these operations. An example is Brown University, which received supplemental funding in 2020 to perform disease research on COVID-19 biospecimens. Healthcare organizations also offer support. For instance, Kaiser Permanente's biobank received a substantial $24.8-million grant from the National Institute of Health in 2009."
        },
        {
            "question": "How much does your organization expend on marketing expenses?",
            "answer": "Typically, marketing expenses account for less than 1.0% of revenue, as many companies are nonprofit organizations that partner with universities, institutes and governments."
        },
        {
            "question": "How can your organization encourage more donations?",
            "answer": "Direct donation of specimens account for nearly half of total acquired specimens by a company active in this industry."
        },
        {
            "question": "What entities does your company partner with?",
            "answer": "Most biobanks are affiliated with at least one or more larger organizations, the majority of which are academic institutions."
        },
        {
            "question": "How has improving biotechnology equipment and advances in genetic research impacted your operations?",
            "answer": "In particular, advances in genetic research stimulated demand for genetic data from preserved tissues and cells, as researchers continue to study specific genomes and cell lines."
        },
        {
            "question": "How often do you replace your equipment, such as freezers or other preservation equipment?",
            "answer": "Although cryogenic freezers and other preservation equipment are costly, technology represents a one-time expense and equipment generally does not need to be upgraded."
        },
        {
            "question": "What impact has increasing regulation had on your short-term growth prospects?",
            "answer": "Increasing regulation or new legislation may potentially inhibit an industry operator's ability to grow in the short-term due to increased compliance costs. Still, regulation will benefit global biobanking a whole, as the international community works together to prevent or combat disease."
        },
        {
            "question": "What regulatory body has oversight on biobanking?",
            "answer": "The Food and Drug Administration (FDA) has developed precise rules and regulations for private biobanks that fall within its jurisdiction."
        },
        {
            "question": "What portion of your financing comes from state or federal governments?",
            "answer": "Among the biobanks surveyed by Genome Medicine, about 57.0% and 12.0% of biobanks were financed by federal and state governments, respectively."
        },
        {
            "question": "How does your organization's profit margins compare to others?",
            "answer": "The average profit margin for an industry operator is about 7.0%"
        },
        {
            "question": "How much of your revenue comes from federal funding? If federal funding diminishes, how will you respond?",
            "answer": "Many cryogenic biobanks rely on funding from a myriad of sources, especially the federal government. Guaranteeing the long-term supply of this funding is crucial for a biobank to continue its operations."
        },
        {
            "question": "Does your company have close relationships with several distributors? How can you cultivate these relationships?",
            "answer": "Given the highly controlled nature of biospecimen storage, distribution costs can be extensive. Mitigating these expenses while maintaining quality is crucial to boosting profit margins."
        },
        {
            "question": "How diverse is your product range? Are you actively working to expand the number of research fields you supply?",
            "answer": "While some biobanks focus on the research of specific diseases, providing an array of biospecimens tends to increase demand from downstream researchers, expanding revenue opportunities."
        },
        {
            "question": "Research and development expenditure",
            "answer": "There has been a historic shortage of viable clinical samples offered by the industry. Consequently, an increase in expenditure on R&D tends to boost demand for biospecimens provided by industry operators."
        },
        {
            "question": "OD - Regulation",
            "answer": "Additional industry-specific legislation tends to increase regulatory compliance costs for industry operators. Given the substantial fixed costs already required in the industry, new regulation is particularly harmful to the industry profit margins."
        }
    ]
}